Medical therapy to reduce postoperative Crohn's disease recurrence

American Journal of Gastroenterology

Volumn 95, Issue 5, 2000, Pages 1139-1146

  Achkar, Jean Paul ^a   Hanauer, Stephen B ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUDESONIDE; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

CHEMOPROPHYLAXIS; CLINICAL TRIAL; CROHN DISEASE; DRUG EFFICACY; HUMAN; ILEOSTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SMALL INTESTINE RESECTION;

ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROHN DISEASE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MESALAMINE; METRONIDAZOLE; RECURRENCE; RISK FACTORS; SULFASALAZINE;

EID: 0034059765     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)00792-9     Document Type: Review

References (51)

1. Rutgeerts P., Geboes K., Vantrappen G., et al. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut. 25:1984;665-672.
2. Olaison G., Smedh K., Sjodahl R. Natural course of Crohn's disease after ileocolonic resection - Endoscopically visualized ileal ulcers preceding symptoms. Gut. 33:1992;331-335.
3. Rutgeerts P., Geboes K., Vantrappen G., et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 99:1990;956-963.
4. McLeod R.S., Wolff B.G., Steinhart H., et al. Risk and significance of endoscopic/radiologic evidence of recurrent Crohn's disease. Gastroenterology. 113:1997;1823-1827.
5. Borley N.R., Mortensen N.J., Jewell D.P. Preventing postoperative recurrence of Crohn's disease. Br J Surg. 84:1997;1493-1502.
6. Sachar D.B. The problem of postoperative recurrence of Crohn's disease. Med Clin North Am. 74:1990;183-188.
7. Lock M.R., Farmer R.G., Fazio V.W., et al. Recurrence and reoperation for Crohn's disease The role of disease location in prognosis . N Engl J Med. 304:1981;1586-1588.
8. Michelassi F., Balestracci T., Chappell R., et al. Primary and recurrent Crohn's Experience with 1379 patients . Ann Surg. 214:1991;230-240.
9. Sachar D.B., Wolfson D.M., Greenstein A.J., et al. Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology. 85:1983;917-921.
10. Heimann T.M., Greenstein A.J., Lewis B., et al. Prediction of early symptomatic recurrence after intestinal resection in Crohn's disease. Ann Surg. 218:1993;294-299.
11. D'Haens G.R., Gasparaitis A.E., Hanauer S.B. Duration of recurrent ileitis after ileocolonic resection correlates with presurgical extent of Crohn's disease. Gut. 36:1995;715-717.
12. Greenstein A.J., Lachman P., Sachar D.B., et al. Perforating and non-perforating indications for repeated operations in Crohn's disease Evidence for two clinical forms . Gut. 29:1988;588-592.
13. Aeberhard P., Berchtold W., Riedtmann H.J., et al. Surgical recurrence of perforating and nonperforating Crohn's disease. Dis Colon Rectum. 39:1996;80-87.
14. Pallone F., Boirvant M., Stazi M.A., et al. Analysis of clinical course of postoperative recurrence in Crohn's disease of distal ileum. Dig Dis Sci. 37:1992;215-219.
15. Lautenbach E., Berlin J.A., Lichtenstein G.R. Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology. 115:1998;259-267.
16. McDonald P.J., Fazio V.W., Farmer R.G., et al. Perforating and nonperforating Crohn's disease - An unpredictable guide to recurrence after surgery. Dis Colon Rectum. 32:1989;117-120.
17. Oberhelman H.A., Kohatsu S., Taylor K.D., et al. Diverting ileostomy in the surgical management of Crohn's disease of the colon. Am J Surg. 115:1968;231-239.
18. Zelas P., Jagelman D.G. Loop ileostomy in the management of Crohn's colitis in the debilitated patient. Ann Surg. 191:1980;164-168.
19. Harper P.H., Truelove S.C., Lee E.C.G., et al. Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis. Gut. 24:1983;106-113.
20. Rutgeerts P. Recurrence of Crohn's disease in the neoterminal ileum after ileal resection Is prevention therapy possible? Netherlands J Med. 45:1994;60-64.
21. Ho I., Greenstein A.J., Bodian C.A., et al. Recurrence of Crohn's disease in end ileostomies. Inflamm Bowel Dis. 1:1995;173-178.
22. Janowitz H.D., Croen E.C., Sachar D.B. The role of the fecal stream in Crohn's disease An historical and analytic review . Inflamm Bowel Dis. 4:1998;29-39.
23. Rutgeerts P., Goboes K., Peeters M., et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet. 338:1991;771-774.
24. D'Haens G.R., Geboes K., Peeters M., et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 114:1998;262-267.
25. Cameron JL, Hamilton SR, Coleman J, et al. Patterns of ileal recurrence in Crohn's disease: A prospective randomized study. Ann Surg 1992:546-52.
26. Sartor R.B. Postoperative recurrence of Crohn's disease The enemy is within the fecal stream . Gastroenterology. 114:1998;398-407. (editorial).
27. Sutherland L.R., Ramcharan S., Bryant H., et al. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology. 98:1990;1123-1128.
28. Cottone M., Rosselli M., Orlando A., et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology. 106:1994;643-648.
29. McLeod R.S. Medical prophylaxis is indicated for the prevention of recurrence of Crohn's disease after surgery. Inflamm Bowel Dis. 1:1995;159-161.
30. Strong S.A. Prognostic parameters of Crohn's disease recurrence. Baillieres Clin Gastroenterol. 12:1998;167-177.
31. Wenckert A., Kristensen M., Eklund A.E., et al. The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease A controlled double-blind trial . Scand J Gastroenterol. 13:1978;161-167.
32. Summers R.W., Switz D.M., Sessions J.T., et al. National Cooperative Crohn's Disease Study Results of drug treatment . Gastroenterology. 77:1979;847-869.
33. Ewe K., Herfath C., Malchow H., et al. Postoperative recurrence of Crohn's disease in relation to radicality of operation and sulfasalazine prophylaxis A multicenter trial . Digestion. 42:1989;224-232.
34. Bergman L., Krause U. Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin) after radical resection for Crohn's disease. Scand J Gastroenterol. 11:1976;651-656.
35. Fiasse R., Fontaine F., Vanheuverzwyn R. Prevention of Crohn's disease recurrences after intestinal resection with Eudragid-L-coated 5-aminosalicylic acid. Preliminary results of a one year double-blind placebo controlled study. Gastroenterology. 100:1991;A208. (abstract).
36. Lochs H., Mayer M., Fleig W.E., et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalazine (Pentasa) in comparison to placebo. Gastroenterology. 112:1997;A1027. (abstract).
37. McLeod R.S., Wolff B.G., Steinhart A.H., et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology. 109:1995;404-413.
38. Sutherland L.R., Martin F., Bailey R.J., et al. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. Gastroenterology. 112:1997;1069-1077.
39. Caprilli R., Andreoli A., Capurso L., et al. Oral mesalazine (Asacol) for the prevention of post-operative recurrence of Crohn's disease. Aliment Pharmacol Ther. 8:1994;35-43.
40. Brignola C., Cottone M., Pera A., et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Gastroenterology. 108:1995;345-349.
41. Florent C., Cortot A., Quandale P., et al. Placebo-controlled trial of mesalazine in the prevention of early endoscopic recurrence after "curative" resection for Crohn's disease. Eur J Gastroenterol Hepatol. 8:1996;229-233.
42. Camma C., Giunta M., Rosselli M., et al. 5-Aminosalicylic acid in the maintenance of Crohn's disease A meta-analysis adjusted for confounding variables . Gastroenterology. 113:1997;1465-1473.
43. Rutgeerts P., Hiele M., Geboes K., et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology. 108:1995;1617-1621.
44. O'Donaghue D.P., Dawson A.W., Powell-Tuck J., et al. Double-blind withdrawal trial of azathioprine as maintenance treatment of Crohn's disease. Lancet. 2:1978;955-957.
45. Pearson DC, May GR, Fick G, et al. Azathioprine for maintenance of remission of Crohn's disease (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford: Update Software, 1999.
46. Korelitz B., Hanauer S., Rutgeerts P., et al. Post-operative prophylaxis with 6-MP, 5-ASA or placebo in Crohn's disease A 2-year multicenter trial . Gastroenterology. 114:1998;A1011. (abstract).
47. Lemann M., Cuillerier E., Bouhnik Y., et al. Azathioprine for prevention of Crohn's recurrence after ileal or colonic resection. Gastroenterology. 110:1996;A948. (abstract).
48. Korelitz B.I., Adler D.J., Mendelsohn R.A., et al. Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease. Am J Gastroenterol. 88:1993;1198-1205.
49. Steinhart AH, Ewe K, Griffiths AM, et al. Corticosteroids for maintaining remission of Crohn's disease (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford: Update Software, 1999.
50. Hamedani R., Feldman R.D., Feagan B.G. Drug development in inflammatory bowel disease Budesonide - A model of targeted therapy . Aliment Pharmacol Ther. 11:(suppl 3):1997;98-107.
51. Hellers G, Cortot A, Jewell D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. Gastroenterology 1999;116:294-30.